Literature DB >> 12408479

Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET.

Mark Lubberink1, Harald Schneider, Mats Bergström, Hans Lundqvist.   

Abstract

Several positron emitting nuclides with applications in PET, such as 76Br, 124I, 110In and 86Y, also emit gamma radiation in their decays. Measured coincidences between annihilation photons and this cascade gamma radiation are essentially true coincidences and the standard PET corrections do not account for them. We investigated the performance of 76Br in 2D and 3D PET, the effect of the gamma radiation emitted by 76Br on quantitative accuracy and the distribution of cascade gamma radiation coincidences in 2D and 3D PET sinograms. A correction method for cascade gamma radiation coincidences was implemented and evaluated. Count rate linearity was affected by the gamma radiation from the 76Br decay. Spatial resolution and sphere recovery were slightly worse for 76Br compared to 18F. Correction for cascade gamma radiation coincidences by subtraction of a linear projection tail fit improved total correction accuracy to similar values as for positron-only emitters such as 18F, and improved image contrast significantly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408479     DOI: 10.1088/0031-9155/47/19/306

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  15 in total

1.  PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction.

Authors:  H G Buchholz; H Herzog; G J Förster; H Reber; O Nickel; F Rösch; P Bartenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-26       Impact factor: 9.236

2.  Assessment of the short-lived non-pure positron-emitting nuclide (120)I for PET imaging.

Authors:  H Herzog; S M Qaim; L Tellmann; S Spellerberg; D Kruecker; H H Coenen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-15       Impact factor: 9.236

Review 3.  Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach.

Authors:  Abass Alavi; Thomas J Werner
Journal:  Diabetologia       Date:  2018-06-29       Impact factor: 10.122

Review 4.  Quantitative imaging of 124I and 86Y with PET.

Authors:  Mark Lubberink; Hans Herzog
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

5.  Correction technique for cascade gammas in I-124 imaging on a fully-3D, Time-of-Flight PET Scanner.

Authors:  Suleman Surti; Ryan Scheuermann; Joel S Karp
Journal:  IEEE Trans Nucl Sci       Date:  2009-06       Impact factor: 1.679

6.  Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT.

Authors:  Fabio P Esteves; Jonathan A Nye; Akbar Khan; Russell D Folks; Raghuveer K Halkar; Ernest V Garcia; David M Schuster; Stamatios Lerakis; Paolo Raggi; John R Votaw
Journal:  J Nucl Cardiol       Date:  2009-11-24       Impact factor: 5.952

7.  Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.

Authors:  Walter Jentzen; Reiner Weise; Jürgen Kupferschläger; Lutz Freudenberg; Wolfgang Brandau; Ronald Bares; Wolfgang Burchert; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-10       Impact factor: 9.236

8.  An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix.

Authors:  Jason S Lewis; Richard Laforest; Farrokh Dehdashti; Perry W Grigsby; Michael J Welch; Barry A Siegel
Journal:  J Nucl Med       Date:  2008-06-13       Impact factor: 10.057

9.  Monte Carlo modeling of cascade gamma rays in (86)Y PET imaging: preliminary results.

Authors:  Xuping Zhu; Georges El Fakhri
Journal:  Phys Med Biol       Date:  2009-06-12       Impact factor: 3.609

10.  dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

Authors:  Nadège Anizan; Thomas Carlier; Cecilia Hindorf; Jacques Barbet; Manuel Bardiès
Journal:  EJNMMI Res       Date:  2012-02-13       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.